These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 11011336

  • 1. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A, Consoli S, Safavian A, Dubanchet A, Safar M.
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [Abstract] [Full Text] [Related]

  • 2. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [Abstract] [Full Text] [Related]

  • 3. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A, Adamopoulos C, Argyriadis P, Bean K, Consoli S, Safar M.
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Payeras AC, Sladek K, Lembo G, Alberici M.
    Clin Drug Investig; 2007 Feb; 27(9):623-32. PubMed ID: 17705571
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
    Malacco E, Varì N, Capuano V, Spagnuolo V, Borgnino C, Palatini P, Val-Syst study.
    Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
    [Abstract] [Full Text] [Related]

  • 6. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
    Prisant LM, Weir MR, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP, Carr AA.
    Am Heart J; 1995 Aug; 130(2):359-66. PubMed ID: 7631621
    [Abstract] [Full Text] [Related]

  • 7. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies.
    Prisant LM, Neutel JM, Papademetriou V, DeQuattro V, Hall WD, Weir MR.
    Am J Ther; 1998 Sep; 5(5):313-21. PubMed ID: 10099075
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cléroux J, Boileau G.
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [Abstract] [Full Text] [Related]

  • 9. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST Investigators.
    JAMA; 2003 Dec 03; 290(21):2805-16. PubMed ID: 14657064
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 03; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 11. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.
    Pediatr Nephrol; 2002 May 03; 17(5):345-50. PubMed ID: 12042891
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
    Manning G, Joy A, Mathias CJ, McDonald CJ, Millar-Craig MW.
    J Hum Hypertens; 1996 Jul 03; 10(7):443-8. PubMed ID: 8880557
    [Abstract] [Full Text] [Related]

  • 13. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Kontula K, Hiltunen TP.
    J Hypertens; 2008 Jun 03; 26(6):1250-6. PubMed ID: 18475165
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.
    Weir MR, Prisant LM, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP.
    Am J Hypertens; 1996 Sep 03; 9(9):854-9. PubMed ID: 8879341
    [Abstract] [Full Text] [Related]

  • 15. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    Kraiczi H, Hedner J, Peker Y, Grote L.
    Am J Respir Crit Care Med; 2000 May 03; 161(5):1423-8. PubMed ID: 10806134
    [Abstract] [Full Text] [Related]

  • 16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 03; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 17. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G, Schmieder R, Calvo C, Asmar R.
    Am J Hypertens; 2006 Jan 03; 19(1):113-21. PubMed ID: 16461202
    [Abstract] [Full Text] [Related]

  • 18. Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.
    Odili AN, Ezeala-Adikaibe B, Ndiaye MB, Anisiuba BC, Kamdem MM, Ijoma CK, Kaptue J, Boombhi HJ, Kolo PM, Shu EN, Thijs L, Staessen JA, Omotoso BA, Kingue S, Ba SA, Lemogoum D, M'Buyamba-Kabangu JR, Ulasi II.
    Trials; 2012 May 17; 13():59. PubMed ID: 22594907
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC, Oh YS, Cha DH, Hong SJ, Won KH, Yoo KD, Rha SW, Ahn YK, Ahn JC, Jang JY, Hong TJ, Cho SK, Park SH, Hyon MS, Nam CW, Chae IH, Yoo BS, Song JM, Jeong JO, Yoon YW, Kim BS, Yang TH, Cho DK, Kim SH, Choi YJ, Ahn JH, Jeon DW, Kim HS.
    Clin Ther; 2018 Jan 17; 40(1):50-63.e3. PubMed ID: 29248384
    [Abstract] [Full Text] [Related]

  • 20. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
    Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek WJ, Dukart G, Goldberg JD, Alemayehu D, Koury K.
    Arch Intern Med; 1994 Jul 11; 154(13):1461-8. PubMed ID: 8018001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.